1. Home
  2. Author
  3. Lenz RA

Lenz RA

References (2)

Title : Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease - Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192
Author(s) : Lenz RA , Pritchett YL , Berry SM , Llano DA , Han S , Berry DA , Sadowsky CH , Abi-Saab WM , Saltarelli MD
Ref : Alzheimer Disease & Associated Disorders , 29 :192 , 2015
Abstract : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192
ESTHER : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192
PubMedSearch : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192
PubMedID: 25973909

Title : The scopolamine model as a pharmacodynamic marker in early drug development - Lenz_2012_Psychopharmacology.(Berl)_220_97
Author(s) : Lenz RA , Baker JD , Locke C , Rueter LE , Mohler EG , Wesnes K , Abi-Saab WM , Saltarelli MD
Ref : Psychopharmacology (Berl) , 220 :97 , 2012
Abstract : Lenz_2012_Psychopharmacology.(Berl)_220_97
ESTHER : Lenz_2012_Psychopharmacology.(Berl)_220_97
PubMedSearch : Lenz_2012_Psychopharmacology.(Berl)_220_97
PubMedID: 21901320